Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 25

Related Articles by Review for PubMed (Select 15829534)

1.

DNA topoisomerase II in therapy-related acute promyelocytic leukemia.

Mistry AR, Felix CA, Whitmarsh RJ, Mason A, Reiter A, Cassinat B, Parry A, Walz C, Wiemels JL, Segal MR, Adès L, Blair IA, Osheroff N, Peniket AJ, Lafage-Pochitaloff M, Cross NC, Chomienne C, Solomon E, Fenaux P, Grimwade D.

N Engl J Med. 2005 Apr 14;352(15):1529-38.

2.
3.

Secondary leukemias induced by topoisomerase-targeted drugs.

Felix CA.

Biochim Biophys Acta. 1998 Oct 1;1400(1-3):233-55. Review.

PMID:
9748598
4.

Chromatin structural elements and chromosomal translocations in leukemia.

Zhang Y, Rowley JD.

DNA Repair (Amst). 2006 Sep 8;5(9-10):1282-97. Epub 2006 Aug 7. Review.

PMID:
16893685
5.
6.

[Chromosome translocations and leukemias induced by inhibitors of topoisomerase II anticarcinogenic drugs].

Dassonneville L, Bailly C.

Bull Cancer. 1998 Mar;85(3):254-61. Review. French.

PMID:
9752316
7.

Therapy-related acute promyelocytic leukaemia.

Bhavnani M, Azzawi SA, Yin JA, Lucas GS.

Br J Haematol. 1994 Jan;86(1):231-2. Review.

PMID:
8011541
8.

Etoposide, topoisomerase II and cancer.

Baldwin EL, Osheroff N.

Curr Med Chem Anticancer Agents. 2005 Jul;5(4):363-72. Review.

PMID:
16101488
9.

Topoisomerase II and leukemia.

Pendleton M, Lindsey RH Jr, Felix CA, Grimwade D, Osheroff N.

Ann N Y Acad Sci. 2014 Mar;1310:98-110. doi: 10.1111/nyas.12358. Epub 2014 Feb 3. Review.

10.

Leukemias related to treatment with DNA topoisomerase II inhibitors.

Felix CA.

Med Pediatr Oncol. 2001 May;36(5):525-35. Review.

PMID:
11340607
11.

Molecular analysis of the t(15;17) translocation in acute promyelocytic leukaemia.

Borrow J, Solomon E.

Baillieres Clin Haematol. 1992 Oct;5(4):833-56. Review.

PMID:
1339190
12.

Molecular biology of therapy-related leukaemias.

Joannides M, Grimwade D.

Clin Transl Oncol. 2010 Jan;12(1):8-14. doi: 10.1007/s12094-010-0460-5. Review.

PMID:
20080465
13.

Etoposide and illegitimate DNA double-strand break repair in the generation of MLL translocations: new insights and new questions.

Sung PA, Libura J, Richardson C.

DNA Repair (Amst). 2006 Sep 8;5(9-10):1109-18. Epub 2006 Jun 30. Review.

PMID:
16809075
14.

Acquired acute myelogenous leukemia after therapy for acute promyelocytic leukemia with t(15;17): a case report and review of the literature.

Betancourt-García RD, Castro J, Fernández AC, López-Enríquez A, Fradera J, Pacheco E.

P R Health Sci J. 2009 Jun;28(2):146-50. Review.

PMID:
19530558
15.

Etoposide-related acute promyelocytic leukemia.

Kudo K, Yoshida H, Kiyoi H, Numata S, Horibe K, Naoe T.

Leukemia. 1998 Aug;12(8):1171-5. Review.

PMID:
9697869
17.

Mechanism of generation of therapy related leukemia in response to anti-topoisomerase II agents.

Cowell IG, Austin CA.

Int J Environ Res Public Health. 2012 Jun;9(6):2075-91. doi: 10.3390/ijerph9062075. Epub 2012 May 31. Review.

18.

The DNA cleavage reaction of topoisomerase II: wolf in sheep's clothing.

Deweese JE, Osheroff N.

Nucleic Acids Res. 2009 Feb;37(3):738-48. doi: 10.1093/nar/gkn937. Epub 2008 Nov 28. Review.

19.

[Therapy-related acute myeloid leukemia: role of DNA repair].

Guièze R, Ravinet A, Hermet E, Maliki Y, de Botton S, Bay JO.

Bull Cancer. 2011 Mar;98(3):247-55. doi: 10.1684/bdc.2011.1325. Review. French.

PMID:
21427028
20.

Topoisomerase II and the response to antileukemic therapy.

Kaufmann SH, Gore SD, Miller CB, Jones RJ, Zwelling LA, Schneider E, Burke PJ, Karp JE.

Leuk Lymphoma. 1998 Apr;29(3-4):217-37. Review.

PMID:
9684921
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk